The Mid-Atlantic Biological Safety Association (MABSA) is a not-for-profit, multi-disciplinary professional organization founded in 1990 for the purpose of promoting the principles of Biological Safety.
MABSA was founded to provide a professional forum for dissemination of information between individuals in this and related fields; to inform the public about the value of biological agents in research and health care, and the role they play in disease as well as in the improvement of the quality of life; to identify new biologically hazardous agents and to determine guidelines for their safe use; to promote the recognition of Biosafety as a scientific discipline.
MABSA provides a regional forum for members to interact and share information on biosafety subjects, such as new guidelines or current concerns with newly recognized agents and with new uses for new agents.
A biosafety topic of interest is presented at each of several dinner meetings held throughout the year. A day long symposium, hosted by a member, is held in the spring.
Many MABSA members are also members of the American Biological Safety Association (ABSA); our associations have mutual goals. In order to encourage maximum regional participation, MABSA membership does not require membership in ABSA.
Soliciting Stakeholder Input for a Revision of “Biosafety in Microbiological and Biomedical Laboratories”
Welcome to the National Academy of Sciences, Engineering, and Medicine’s page on Soliciting Stakeholder Input for a Revision of “Biosafety in Microbiological and Biomedical Laboratories.”
Since its publication by National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) in 1984 the Biosafety in Microbiological and Biomedical Laboratories (BMBL) has become the cornerstone of the practice of biosafety in the United States and in many countries around the world. The BMBL has been revised periodically over the past three decades to refine the guidance it provides based on new knowledge and experiences – allowing it to remain as a relevant, valuable, and authoritative reference for the microbiological and biomedical community.
Seven years after the release of the BMBL 5th edition, a revision based on input from a broader set of stakeholders is being considered by the NIH and the CDC. This virtual town hall has been created for users of the BMBL to share their thoughts on the next revision of this document, particularly which information should be deleted, modified, or added. Common themes from this virtual town hall will be further discussed in a workshop on May 12, 2016 in Washington, DC, click here to register. The virtual town hall will be open for comments from April 4 to May 13, 2016. The virtual town hall and workshop will be moderated by a 3-person steering committee appointed by the Academies. For more information on the members of the committee, click on the steering committee tab at the top of this page.
To participate in the virtual town hall discussion, click on the virtual town hall tab at the top of this page and select which section you would like to comment on. To make a general comment, select the general comments page.
If you have questions, send an email to: email@example.com
Want to promote your corporate brand or association identity instantly to the biosafety community?
MABSA now offers companies and associations an opportunity to increase their visibility by making their organization logo visible to our visitors every day. As a sponsor, your company's or association logo will appear prominently on the Sponsor page of our website. Comprised of a graphic of your organization's logo, the logos link directly to the URL of your choice.
By becoming a sponsor of MABSA, your company or organization helps foster the passion for excellence in biological safety. Click here for the sponsorship application.